DAPK1 and acute kidney injury: Administration of DAPK1 inhibitor or genetic knockout of DAPK1 prolongs survival, reverses exacerbation of AKI and accelerates Scr, BUN as well as lactate clearance in septic mice, implicating that DAPK1 is a promising therapeutic target to manage septic AKI.